Search Results - "Alexander, Graeme J.M"

Refine Results
  1. 1

    Senescence in chronic liver disease: Is the future in aging? by Aravinthan, Aloysious D, Alexander, Graeme J.M

    Published in Journal of hepatology (01-10-2016)
    “…Summary Cellular senescence is a fundamental, complex mechanism with an important protective role present from embryogenesis to late life across all species…”
    Get full text
    Journal Article
  2. 2

    Selective insulin resistance in hepatocyte senescence by Aravinthan, Aloysious, Challis, Benjamin, Shannon, Nicholas, Hoare, Matthew, Heaney, Judith, Alexander, Graeme J.M.

    Published in Experimental cell research (01-02-2015)
    “…Insulin resistance has been described in association with chronic liver disease for decades. Hepatocyte senescence has been demonstrated in chronic liver…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Induced pluripotent stem cells: From Nobel Prizes to clinical applications by Rashid, S. Tamir, Alexander, Graeme J.M

    Published in Journal of hepatology (01-03-2013)
    “…Advances in basic hepatology have been constrained for many years by the inability to culture primary hepatocytes in vitro, until just over five years ago when…”
    Get full text
    Journal Article
  5. 5

    γ-H2AX + CD8+ T lymphocytes cannot respond to IFN-α, IL-2 or IL-6 in chronic hepatitis C virus infection by Hoare, Matthew, Shankar, Arun, Shah, Meera, Rushbrook, Simon, Gelson, William, Davies, Susan, Akbar, Arne, Alexander, Graeme J.M

    Published in Journal of hepatology (01-05-2013)
    “…Background & Aims Age is the dominant prognostic factor influencing the natural history of hepatitis C virus (HCV) infection and treatment response…”
    Get full text
    Journal Article
  6. 6

    CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection by Hoare, Matthew, Gelson, William T.H, Das, Abhi, Fletcher, Jean M, Davies, Susan E, Curran, Martin D, Vowler, Sarah L, Maini, Mala K, Akbar, Arne N, Alexander, Graeme J.M

    Published in Journal of hepatology (01-08-2010)
    “…Background & Aims Increasing age is associated with impaired immune function and in chronic HCV infection specifically, with progressive fibrosis, liver…”
    Get full text
    Journal Article
  7. 7

    Comparison of endothelin receptors in normal versus cirrhotic human liver and in the liver from endothelial cell-specific ETB knockout mice by Ling, Lowell, Kuc, Rhoda E., Maguire, Janet J., Davie, Neil J., Webb, David J., Gibbs, Paul, Alexander, Graeme J.M., Davenport, Anthony P.

    Published in Life sciences (1973) (15-10-2012)
    “…Endothelin (ET) antagonists show promise in animal models of cirrhosis and portal hypertension. The aim was to pharmacologically characterise the expression of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A single centre experience of liver disease in adults with cystic fibrosis 1995–2006 by Nash, K.L, Allison, M.E, McKeon, D, Lomas, D.J, Haworth, C.S, Bilton, D, Alexander, Graeme J.M

    Published in Journal of cystic fibrosis (01-05-2008)
    “…Abstract Background Liver disease is an important cause of death in adults with cystic fibrosis (CF). Ursodeoxycholic acid (UDCA) may slow progression…”
    Get full text
    Journal Article
  10. 10

    Event-biased referral can distort estimation of hepatitis C virus progression rate to cirrhosis, and of prognostic influences by Fu, Bo, Tom, Brian D.M, Delahooke, Toby, Alexander, Graeme J.M, Bird, Sheila M

    Published in Journal of clinical epidemiology (01-11-2007)
    “…Abstract Objective To investigate how cirrhosis-biased referral to liver clinics can explain the wide variation in progression rates for differently recruited…”
    Get full text
    Journal Article
  11. 11

    Early indicators of prognosis in fulminant hepatic failure by O'Grady, J G, Alexander, G J, Hayllar, K M, Williams, R

    Published in Gastroenterology (New York, N.Y. 1943) (01-08-1989)
    “…The successful use of orthotopic liver transplantation in fulminant hepatic failure has created a need for early prognostic indicators to select the patients…”
    Get more information
    Journal Article
  12. 12

    Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure by Harrison, Phillip M, Wendon, Julia A, Gimson, Alexander E.S, Alexander, Graeme J.M, Williams, Roger

    Published in The New England journal of medicine (27-06-1991)
    “…IN normal subjects tissue oxygen consumption is maintained at around 110 ml per minute per square meter of body-surface area, and changes in oxygen delivery…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts by Evans, Paul C, Coleman, Nick, Wreghitt, Tim G, Wight, Derek G.D, Alexander, Graeme J.M

    Published in Journal of hepatology (01-11-1999)
    “…Background/Aim: Chronic rejection is an important cause of graft loss following liver transplantation. A number of risk factors for chronic rejection have been…”
    Get full text
    Journal Article
  15. 15

    High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis by Lau, J Y, Bain, V G, Davies, S E, O'Grady, J G, Alberti, A, Alexander, G J, Williams, R

    Published in Gastroenterology (New York, N.Y. 1943) (01-03-1992)
    “…The expression of hepatitis B viral antigens was quantified in liver tissue from four transplant recipients with fibrosing cholestatic hepatitis (FCH) and…”
    Get more information
    Journal Article
  16. 16

    The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure by Keays, R T, Alexander, G J, Williams, R

    Published in Journal of hepatology (1993)
    “…Thirty-six of 68 consecutive patients with fulminant hepatic failure (FHF) progressing to grade 4 encephalopathy who had extradural ICP monitors inserted were…”
    Get more information
    Journal Article
  17. 17

    Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease by Aravinthan, Aloysious, Pietrosi, Giada, Hoare, Matthew, Jupp, James, Marshall, Aileen, Verrill, Clare, Davies, Susan, Bateman, Adrian, Sheron, Nick, Allison, Michael, Alexander, Graeme J M

    Published in PloS one (23-09-2013)
    “…Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol…”
    Get full text
    Journal Article
  18. 18

    The senescent hepatocyte gene signature in chronic liver disease by Aravinthan, Aloysious, Shannon, Nicholas, Heaney, Judith, Hoare, Matthew, Marshall, Aileen, Alexander, Graeme J.M.

    Published in Experimental gerontology (01-12-2014)
    “…Hepatocyte senescence is associated closely with fibrosis stage and an adverse outcome in chronic liver disease, but it is uncertain whether there is a causal…”
    Get full text
    Journal Article
  19. 19

    Hepatitis C Virus Genomic Variability in Untreated and Immunosuppressed Patients by LAWAL, ZARAH, PETRIK, JURAJ, WONG, VOI-SHIM, ALEXANDER, GRAEME J.M, ALLAIN, JEAN-PIERRE

    Published in Virology (New York, N.Y.) (03-02-1997)
    “…To investigate whether immune pressure enhances the genetic diversity of the hepatitis C virus (HCV) hypervariable region 1, nucleotide sequences were compared…”
    Get full text
    Journal Article
  20. 20

    Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver by Verma, Suman, Tachtatzis, Phaedra, Penrhyn-Lowe, Sue, Scarpini, Cinzia, Jurk, Diana, Von Zglinicki, Thomas, Coleman, Nick, Alexander, Graeme J. M.

    Published in Hepatology (Baltimore, Md.) (01-10-2012)
    “…Telomeres, a validated biomarker of aging, comprise multiple nucleotide repeats capping chromosomes that shorten with each cell cycle until a critical length…”
    Get full text
    Journal Article